The Torrex Chiesi Group, with its Headquarters in Austria, is a regional structure which represents the Chiesi Group in the Central Eastern European countries, including Russia and the countries within the Commonwealth of Independent States (CIS). Besides drugs in the respiratory, rheumatology and neonatology fields, the Torrex Chiesi Group portfolio includes products indicated for anaesthesiology, intensive care, systemic antifungal treatment and addiction therapy.
The Torrex Chiesi Group is actively seeking further in-licensing products in specific business areas, using its significant presence in Central Eastern European Countries (CEEC).